Pri-Med Podcasts

Avoiding Treatment Delays: Case Conversations in Type 2 Diabetes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-conversation-t2dm-part-2
Overview: In the context of a clinical case, faculty will emphasize the importance of developing a guideline-directed diabetes care management plan that places GLP-1 RA therapy before insulin.

Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2
Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. 
The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-addressing-challenges-pt1
Overview: Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD.
The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Proving Cassandra Wrong: The Case For Migraine Prevention

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-for-migraine-prevention
Overview: This podcast will focus on the case of a patient with migraine attacks that have been increasing in frequency and the disability they cause. Faculty will discuss when to initiate preventive migraine treatment and consider medication options for this patient that will take into account her comorbid conditions and potential issues with adherence.

Your Questions About Migraine Work-Up And Prevention Answered

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine-pt2
Overview: In this podcast, Drs. Dawn Buse and Michael Ready will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include red flags requiring evaluation for serious secondary causes of headache, tips on encouraging patients to use headache diaries, the role of supplements in migraine prevention, and more!

The Best Evidence for Treating Fibromyalgia - Frankly Speaking EP 294

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294
 
Overview: Fibromyalgia is a common and difficult to diagnose disease, with highly subjective symptoms. Another challenge is that treatment is dependent on a patient’s implementation lifestyle changes. This brief podcast walks you through the diagnosis of fibromyalgia and offers best evidence on effective treatments.
 
Episode resource links:
Mediations:  JAMA Netw Open. 2022;5(5):e2212939
Acupuncture:  J Pain Res. 2022; 15: 315–329
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Wait Before Writing That Antibiotic Prescription! Is it appropriate? - Frankly Speaking EP 293

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293
 
Overview: Evidence informs us that almost one-third of antibiotic prescriptions written for children in the United States are inappropriate, meaning they are not in line with evidence-based guidelines. Antibiotics are tremendous tools and beneficial when used appropriately; however, as with all pharmacological therapy, there are risks of adverse effects and healthcare cost. When prescribed inappropriately, they unnecessarily put children at risk and cause financial burden on individuals and the system. Please join the podcast team as we discuss recent evidence on these risks and burden and consider how this evidence can help improve practice. 
 
Episode resource links:
Butler AM, Brown DS, Durkin MJ, et al. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. JAMA Netw Open.2022;5(5):e2214153. doi:10.1001/jamanetworkopen.2022.14153
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

To Add Insulin or Not to Add Insulin: Case Conversations in Type 2 Diabetes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-conversation-t2dm
Overview: In the context of a clinical case, faculty will emphasize the importance of developing a guideline-directed diabetes care management plan that places GLP-1 RA therapy before insulin.

Reducing the Risk of Alcohol-Associated Liver Disease - Frankly Speaking EP 292

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-292
 
Overview: Alcohol use disorder is common, but effective medications to treat this disorder are not widely prescribed in the outpatient primary care setting, despite being available and having relatively good formulary coverage. Join us to hear how the use of medical treatment can decrease the incidence and progression of alcohol-associated liver disease.
 
Episode resource links:
Augustin G. L. Vannier et al, Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder, JAMA Network Open (2022).  DOI: 10.1001/jamanetworkopen.2022.13014
 
 
Tetreault JM, O'Connor PG. Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. Published April 28, 2022. Accessed June 11, 2022. 
 
Holt SR, Tetrault, JM. Ambulatory Management of alcohol withdrawal. UpToDate. Published May 19, 2022. Accessed June 11, 2022.
 
Holt SR. Approach to treating alcohol use disorder. UpToDate. Published March 22, 2022. Accessed June 11, 2022.
 
Guest: Jillian Joseph, MSPAS, PA-C
Music Credit: Richard Onorato

Is Less More When Treating BP in Older Adults? - Frankly Speaking EP 291

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291
 
Overview: Concerns have been raised over guideline recommendations for lowering systolic blood pressure (BP) to 60 years. To achieve such targets often requires intensive BP treatments, which can result in harms from syncope or falls. Join us to review the results of a recently published meta-analysis done to estimate the time needed to potentially derive clinical benefit from such BP treatments in patients 60 years and older. 
 
Episode resource links:
JAMA Intern Med. 2022;182(6):660-667. doi:10.1001/jamainternmed.2022.1657
 
Guest: Robert A. Baldor, MD
 
Music Credit: Richard Onorato